- Home
- DMAC vs AJX Comparison
DMAC vs AJX Comparison
Compare DMAC & AJX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- AJX
- Stock Information
- Founded
- DMAC 2000
- AJX 2014
- Country
- DMAC United States
- AJX United States
- Employees
- DMAC N/A
- AJX N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- AJX Real Estate Investment Trusts
- Sector
- DMAC Health Care
- AJX Real Estate
- Exchange
- DMAC Nasdaq
- AJX Nasdaq
- Market Cap
- DMAC 172.7M
- AJX 141.2M
- IPO Year
- DMAC N/A
- AJX 2015
- Fundamental
- Price
- DMAC $4.70
- AJX $3.00
- Analyst Decision
- DMAC Strong Buy
- AJX Buy
- Analyst Count
- DMAC 3
- AJX 2
- Target Price
- DMAC $7.00
- AJX $6.00
- AVG Volume (30 Days)
- DMAC 105.5K
- AJX 143.5K
- Earning Date
- DMAC 11-13-2024
- AJX 10-21-2024
- Dividend Yield
- DMAC N/A
- AJX 8.03%
- EPS Growth
- DMAC N/A
- AJX N/A
- EPS
- DMAC N/A
- AJX N/A
- Revenue
- DMAC N/A
- AJX N/A
- Revenue This Year
- DMAC N/A
- AJX N/A
- Revenue Next Year
- DMAC N/A
- AJX N/A
- P/E Ratio
- DMAC N/A
- AJX N/A
- Revenue Growth
- DMAC N/A
- AJX N/A
- 52 Week Low
- DMAC $2.14
- AJX $2.92
- 52 Week High
- DMAC $4.95
- AJX $6.01
- Technical
- Relative Strength Index (RSI)
- DMAC 63.73
- AJX 40.07
- Support Level
- DMAC $3.96
- AJX $2.92
- Resistance Level
- DMAC $4.21
- AJX $3.05
- Average True Range (ATR)
- DMAC 0.21
- AJX 0.09
- MACD
- DMAC 0.02
- AJX -0.00
- Stochastic Oscillator
- DMAC 87.64
- AJX 28.04
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About AJX Great Ajax Corp.
Great Ajax Corp is an externally managed real estate company. The company's primary business is acquiring, investing in and managing a portfolio of mortgage loans. The company is focused on acquisitions of re-performing loans (RPLs) including residential mortgage loans and small balance commercial mortgage loans (SBC loans). Great Ajax operates in a single segment. The company also holds real-estate owned (REO) properties acquired upon the foreclosure, other settlement of owned non-performing loans.